Organovo Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
April 24, 2017 17:00 ET
|
Organovo, Inc.
SAN DIEGO, April 24, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo” or the “Company”), a three-dimensional biology company focused on delivering scientific and medical...
Organovo Announces CEO Transition
April 11, 2017 16:05 ET
|
Organovo, Inc.
Taylor J. Crouch Named Chief Executive Officer, Effective April 24, 2017 Keith Murphy to Step Down as Chief Executive Officer, Remains on Board of Directors SAN DIEGO, April 11, 2017 (GLOBE...
Organovo and Its Customers Present Data Supporting 3D Bioprinted Liver and Kidney Tissues for Drug Toxicity Testing
March 13, 2017 08:05 ET
|
Organovo, Inc.
SAN DIEGO, March 13, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using...
Organovo to Present at 29th Annual Roth Conference
March 09, 2017 08:05 ET
|
Organovo, Inc.
SAN DIEGO, March 09, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using...
Organovo Publishes Data Describing Physiology of 3D Bioprinted Human Kidney Tissues for Drug Toxicity Testing
February 21, 2017 08:05 ET
|
Organovo, Inc.
SAN DIEGO, Feb. 21, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using...
Organovo Announces Fiscal Third-Quarter 2017 Results; Company Updates Full-Year Fiscal 2017 Total Revenue Outlook
February 09, 2017 16:05 ET
|
Organovo, Inc.
SAN DIEGO, Feb. 09, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using...
Organovo Collaborates With Professor Melissa Little for Kidney Tissue Research
January 24, 2017 08:05 ET
|
Organovo, Inc.
SAN DIEGO and MELBOURNE, Australia and SPRINGFIELD, Va., Jan. 24, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on...
Organovo Announces Release Date for Fiscal Third-Quarter 2017 Financial Results
January 19, 2017 08:05 ET
|
Organovo, Inc.
SAN DIEGO, Jan. 19, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using...
Organovo Signs Exclusive Distributor Agreement With Cosmo Bio (Japan)
December 14, 2016 08:05 ET
|
Organovo, Inc.
SAN DIEGO, Dec. 14, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
Organovo Presents First Preclinical Data on 3D Bioprinted Human Liver Tissues at TERMIS-Americas Meeting
December 13, 2016 08:05 ET
|
Organovo, Inc.
SAN DIEGO, Dec. 13, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...